RESMED INC — Director's Dealing 2011

Jan 10, 2011

AMENDED Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity ResMed Inc. (RMD) ABN 46 064 514 852

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Peter C. Farrell
Date of last notice	December 24, 2010

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	DirectIndirect in 3 Grantee Retained AnnuityTrusts
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.
Date of change	(1) December 29, 2010 – Gift (equivalentto US dated transaction of December28, 2010)(2) December 30, 2010 Sale (equivalent toUS dated transaction of December 29,2010)
No. of securities held prior to change	394,268 shares held directly;600,000 shares held indirectly by 3Grantee Retained Annuity Trusts StockOptions – 1,794,320
Class	Common Stock
Number acquired	(1)138,962 shares returned from indirect**to direct shareholdings **

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed	(2) 61,038 shares
Value/Consideration	(1) Estimated value of gift - US$4,869,228;
Note: If consideration is non-cash, provide details and estimatedvaluation	(2) Sale of shares - US$2,139,644.36
No. of securities held after change	533,230 shares held directly;
	600,000 shares held indirectly by 3
	Grantee Retained Annuity Trusts (post
	split);
	Stock Options – 1,794,320
Nature of change	On-market gift and trade pursuant to
Example: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back	10b5-1 trading plan entered into during anopen trading window.
	(1) Represents distribution from the
	Peter C. Farrell December 2009
	Annuity Trust (the “Trust”) to the
	Peter C. Farrell Family Trust. Per
	the terms of the Trust, 90% of the
	original value was to be
	transferred back to Dr. Farrell at
	the end of the first year.
	(2) Represents the sale of the
	remaining shares in the Trust for
	cash, which was retained by the
	Trust.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired
Interest disposed

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

AMENDED Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts No for transaction #1; detailed above traded during a[+] closed period Yes for transaction #2 where prior written clearance was required? If so, was prior written clearance provided to allow Yes as to transaction #2. the trade to proceed during this period? If prior written clearance was provided, on what Trade was executed pursuant date was this provided? to 10b5-1 trading plan approved on November 23, 2010.

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3